Titan Pharmaceuticals Inc. posted a fourth-quarter net loss nearly triple the previous year's as the company ramped up research and development
South San Francisco-based Titan (OTCBB: TTNP) had a fourth-quarter net loss of $4.3 million, or 5 cents per share, compared with a loss of $1.5 million, or 2 cents per share, in the same quarter of 2009.
No comments:
Post a Comment